DCLK1 and colorectal carcinoma: In contrast, exogenously expressed DCLK1 led the proliferative potential and the self‐renewal ability of CRC cells to be enhanced, and the proportion of CD44+ and CD133+ CRC cells to be increased (Figures 2B and S2C,D).